09/03/2026
Register today for our free webinar, “The SIGNAL Study: Using Home-Based Treatments to Advance ME/CFS and Long Covid Research.”
Solve selected the Renegade Research team for a Catalyst award to fund the SIGNAL study, which is built around a device lending library through which people diagnosed with ME/CFS and Long Covid may borrow promising therapeutic devices, shipped directly to their homes at no cost, for a three-month lending period.
While borrowing, participants contribute standardized longitudinal data through the Brain Inflammation Collaborative unhide® online health and research platform. This allows each lending cycle to be a real-world research opportunity.
In this webinar, we’ll hear from Renegade Research team members–scientists and people living with ME/CFS and Long Covid–as they discuss the study's goals, its patient-centered design, how results will be shared quickly to help patients, clinicians, and researchers make more informed decisions, and how you can get involved.
Sign up for the webinar here:
https://ow.ly/G9qk50ZIvx8